Petrelintide
ZUPREME-3
Roche · Phase 3 · Recruiting · Enrollment 3900
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Petrelintide
Roche · Phase 3 · Recruiting · Enrollment 3900
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.